Blog
Canadian company develops nose-to-brain technology for fast-acting cannabinoid treatments.
The Canadian company PreveCeutical Medical has developed a sustained-release CBD formulation of their Sol-gel pain-relief technology. These easy-to-use treatments release cannabinoids into the central nervous system through nasal mucosal tissue.